Hybrid Drugs—A Strategy for Overcoming Anticancer Drug Resistance?

Despite enormous progress in the treatment of many malignancies, the development of cancer resistance is still an important reason for cancer chemotherapy failure. Increasing knowledge of cancers’ molecular complexity and mechanisms of their resistance to anticancer drugs, as well as extensive clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Szumilak, Marta, Wiktorowska-Owczarek, Anna, Stanczak, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124695/
https://www.ncbi.nlm.nih.gov/pubmed/33946916
http://dx.doi.org/10.3390/molecules26092601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8124695/
https://www.ncbi.nlm.nih.gov/pubmed/33946916
http://dx.doi.org/10.3390/molecules26092601

Ejemplares similares